Apr 25, 2024 / NTS GMT
Presentation
Apr 25, 2024 / NTS GMT
=====================
Corporate Participants
=====================
* Atsushi Kitamura
Astellas Pharma Inc. - CFO
* Claus Zieler
Astellas Pharma Inc. - Chief Commercial Officer
* Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations
* Naoki Okamura
Astellas Pharma Inc. - President, CEO & Director
* Tadaaki Taniguchi
Astellas Pharma Inc. - Chief Medical Officer
* Yoshitsugu Shitaka
Astellas Pharma Inc. - Chief Scientific Officer & Senior Managing Executive Officer
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kasumi Haruta
UBS Investment Bank, Research Division - Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Miki Sogi
Astellas Pharma Inc
(OTCPK:ALPMF)
$
11.1275
0 (0%)
Market Cap: 20.04 Bil
Enterprise Value: 23.95 Bil
PE Ratio: 56.39
PB Ratio: 2.01
GF Score: 87/100 Full Year 2024 Astellas Pharma Inc Earnings Presentation Transcript
Apr 25, 2024 / NTS GMT
Release Date Price:
$9.84
(+3.59%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot